These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29708838)

  • 21. Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement.
    Yan AC; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):194-199. PubMed ID: 29883295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.
    Juliano R; Alam MR; Dixit V; Kang H
    Nucleic Acids Res; 2008 Jul; 36(12):4158-71. PubMed ID: 18558618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown.
    Wittrup A; Ai A; Liu X; Hamar P; Trifonova R; Charisse K; Manoharan M; Kirchhausen T; Lieberman J
    Nat Biotechnol; 2015 Aug; 33(8):870-6. PubMed ID: 26192320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee SH; Castagner B; Leroux JC
    Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Measurement of Cytosolic and Nuclear Penetration of Oligonucleotide Therapeutics.
    Deprey K; Batistatou N; Debets MF; Godfrey J; VanderWall KB; Miles RR; Shehaj L; Guo J; Andreucci A; Kandasamy P; Lu G; Shimizu M; Vargeese C; Kritzer JA
    ACS Chem Biol; 2022 Feb; 17(2):348-360. PubMed ID: 35034446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape.
    Gilleron J; Querbes W; Zeigerer A; Borodovsky A; Marsico G; Schubert U; Manygoats K; Seifert S; Andree C; Stöter M; Epstein-Barash H; Zhang L; Koteliansky V; Fitzgerald K; Fava E; Bickle M; Kalaidzidis Y; Akinc A; Maier M; Zerial M
    Nat Biotechnol; 2013 Jul; 31(7):638-46. PubMed ID: 23792630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of CPP Delivery Mechanisms of Oligonucleotides.
    El Boujnouni N; van Asbeck AH; Dieker J; Wansink DG; Brock R
    Methods Mol Biol; 2022; 2383():197-210. PubMed ID: 34766291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides.
    Weng A; Manunta MD; Thakur M; Gilabert-Oriol R; Tagalakis AD; Eddaoudi A; Munye MM; Vink CA; Wiesner B; Eichhorst J; Melzig MF; Hart SL
    J Control Release; 2015 May; 206():75-90. PubMed ID: 25758332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways.
    Liang XH; Sun H; Nichols JG; Allen N; Wang S; Vickers TA; Shen W; Hsu CW; Crooke ST
    Nucleic Acids Res; 2018 Nov; 46(19):10225-10245. PubMed ID: 30239896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-Specific Delivery of Oligonucleotides.
    Xia X; Pollock N; Zhou J; Rossi J
    Methods Mol Biol; 2019; 2036():17-50. PubMed ID: 31410789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct effects of endosomal escape and inhibition of endosomal trafficking on gene delivery via electrotransfection.
    Cervia LD; Chang CC; Wang L; Yuan F
    PLoS One; 2017; 12(2):e0171699. PubMed ID: 28182739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeutics.
    Finicle BT; Eckenstein KH; Revenko AS; Anderson BA; Wan WB; McCracken AN; Gil D; Fruman DA; Hanessian S; Seth PP; Edinger AL
    Nucleic Acids Res; 2023 Feb; 51(4):1583-1599. PubMed ID: 36727438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA.
    Luyet PP; Falguières T; Pons V; Pattnaik AK; Gruenberg J
    Traffic; 2008 Dec; 9(12):2279-90. PubMed ID: 18817529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.
    Wang Y; Shen W; Liang XH; Crooke ST
    Nucleic Acid Ther; 2019 Dec; 29(6):343-358. PubMed ID: 31429620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.
    Ossipov DA
    Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the role of methacrylic acid copolymers in the intracellular delivery of antisense oligonucleotides.
    Yessine MA; Meier C; Petereit HU; Leroux JC
    Eur J Pharm Biopharm; 2006 May; 63(1):1-10. PubMed ID: 16364618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery of RNA Therapeutics: The Great Endosomal Escape!
    Dowdy SF; Setten RL; Cui XS; Jadhav SG
    Nucleic Acid Ther; 2022 Oct; 32(5):361-368. PubMed ID: 35612432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
    Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
    J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.
    Miller CM; Tanowitz M; Donner AJ; Prakash TP; Swayze EE; Harris EN; Seth PP
    Nucleic Acid Ther; 2018 Jun; 28(3):119-127. PubMed ID: 29425080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.
    Roth CM
    Biophys J; 2005 Oct; 89(4):2286-95. PubMed ID: 16055530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.